Name | Glendale Center |
---|---|
Location | 4 Hazel Ave, Naugatuck, Connecticut |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 120 |
Occupancy Rate | 75.33% |
Medicare ID (CCN) | 075240 |
Legal Business Name | 4 Hazel Avenue Operations Llc |
Ownership Type | For Profit - Limited Liability Company |
NPI Number | 1194030577 |
Organization Name | GENESIS ELDERCARE REHAB SVCS |
Address | 4 Hazel Ave, Naugatuck, CT 06770 |
Phone Number | 203-723-1456 |
News Archive
For nurses working in elder care facilities, the type of facility ownership can affect job insecurity and stability, reports a paper in the March issue of Advances in Nursing Science. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
The International Vaccine Institute, a Seoul, Korea-based international organization, announced today that the Swedish International Cooperation Agency will continue to support IVI's mission to accelerate vaccine research and development for global health with a total contribution of SEK 50 million (approximately 5.24 million USD) over the next five years as part of a longstanding partnership between the Swedish government and IVI.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced the publication of a research article in Bioorganic & Medicinal Chemistry Letters on the anti-tumor activity of RX-8243 and its analogues.
RegeneRx Biopharmaceuticals, Inc. announced today that the Company has been included on MDB Capital Group's "Best & Brightest" innovators list of 150 companies for 2011. Criterion for inclusion is a ranking in the 90th percentile for technology leadership from more than 1,500 companies with U.S. patents granted, as rated by PatentVest®, MDB's proprietary, intellectual property (IP), business intelligence database.
› Verified 9 days ago
NPI Number | 1396792289 |
Organization Name | GENESIS HEALTH VENTURES OF NAUGATUCK, INC. |
Doing Business As | GLENDALE CENTER |
Address | 4 Hazel Ave, Naugatuck, CT 06770 |
Phone Number | 203-723-1456 |
News Archive
For nurses working in elder care facilities, the type of facility ownership can affect job insecurity and stability, reports a paper in the March issue of Advances in Nursing Science. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
The International Vaccine Institute, a Seoul, Korea-based international organization, announced today that the Swedish International Cooperation Agency will continue to support IVI's mission to accelerate vaccine research and development for global health with a total contribution of SEK 50 million (approximately 5.24 million USD) over the next five years as part of a longstanding partnership between the Swedish government and IVI.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced the publication of a research article in Bioorganic & Medicinal Chemistry Letters on the anti-tumor activity of RX-8243 and its analogues.
RegeneRx Biopharmaceuticals, Inc. announced today that the Company has been included on MDB Capital Group's "Best & Brightest" innovators list of 150 companies for 2011. Criterion for inclusion is a ranking in the 90th percentile for technology leadership from more than 1,500 companies with U.S. patents granted, as rated by PatentVest®, MDB's proprietary, intellectual property (IP), business intelligence database.
› Verified 9 days ago
NPI Number | 1427239946 |
Organization Name | 4 HAZEL AVENUE OPERATIONS LLC |
Doing Business As | GLENDALE CENTER |
Address | 4 Hazel Ave, Naugatuck, CT 06770 |
Phone Number | 203-723-1456 |
News Archive
For nurses working in elder care facilities, the type of facility ownership can affect job insecurity and stability, reports a paper in the March issue of Advances in Nursing Science. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
The International Vaccine Institute, a Seoul, Korea-based international organization, announced today that the Swedish International Cooperation Agency will continue to support IVI's mission to accelerate vaccine research and development for global health with a total contribution of SEK 50 million (approximately 5.24 million USD) over the next five years as part of a longstanding partnership between the Swedish government and IVI.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced the publication of a research article in Bioorganic & Medicinal Chemistry Letters on the anti-tumor activity of RX-8243 and its analogues.
RegeneRx Biopharmaceuticals, Inc. announced today that the Company has been included on MDB Capital Group's "Best & Brightest" innovators list of 150 companies for 2011. Criterion for inclusion is a ranking in the 90th percentile for technology leadership from more than 1,500 companies with U.S. patents granted, as rated by PatentVest®, MDB's proprietary, intellectual property (IP), business intelligence database.
› Verified 9 days ago
NPI Number | 1669149738 |
Organization Name | COMPLETE CARE AT GLENDALE LLC |
Address | 4 Hazel Ave, Naugatuck, CT 06770 |
Phone Number | 203-723-1456 |
News Archive
For nurses working in elder care facilities, the type of facility ownership can affect job insecurity and stability, reports a paper in the March issue of Advances in Nursing Science. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
The International Vaccine Institute, a Seoul, Korea-based international organization, announced today that the Swedish International Cooperation Agency will continue to support IVI's mission to accelerate vaccine research and development for global health with a total contribution of SEK 50 million (approximately 5.24 million USD) over the next five years as part of a longstanding partnership between the Swedish government and IVI.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced the publication of a research article in Bioorganic & Medicinal Chemistry Letters on the anti-tumor activity of RX-8243 and its analogues.
RegeneRx Biopharmaceuticals, Inc. announced today that the Company has been included on MDB Capital Group's "Best & Brightest" innovators list of 150 companies for 2011. Criterion for inclusion is a ranking in the 90th percentile for technology leadership from more than 1,500 companies with U.S. patents granted, as rated by PatentVest®, MDB's proprietary, intellectual property (IP), business intelligence database.
› Verified 9 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
For nurses working in elder care facilities, the type of facility ownership can affect job insecurity and stability, reports a paper in the March issue of Advances in Nursing Science. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
The International Vaccine Institute, a Seoul, Korea-based international organization, announced today that the Swedish International Cooperation Agency will continue to support IVI's mission to accelerate vaccine research and development for global health with a total contribution of SEK 50 million (approximately 5.24 million USD) over the next five years as part of a longstanding partnership between the Swedish government and IVI.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced the publication of a research article in Bioorganic & Medicinal Chemistry Letters on the anti-tumor activity of RX-8243 and its analogues.
RegeneRx Biopharmaceuticals, Inc. announced today that the Company has been included on MDB Capital Group's "Best & Brightest" innovators list of 150 companies for 2011. Criterion for inclusion is a ranking in the 90th percentile for technology leadership from more than 1,500 companies with U.S. patents granted, as rated by PatentVest®, MDB's proprietary, intellectual property (IP), business intelligence database.
› Verified 9 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $19383 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 22.75 | 14.46 |
Percentage of long-stay residents who lose too much weight | 14.84 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 36.36 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.67 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 2.86 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 1.38 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 4.1 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 96.53 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 11.37 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 82.02 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 1.22 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 36.67 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 19.26 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 9.91 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 75.7 | 95.98 |
Percentage of short-stay residents who made improvements in function | 69.2 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 83.68 | 82.93 |
News Archive
For nurses working in elder care facilities, the type of facility ownership can affect job insecurity and stability, reports a paper in the March issue of Advances in Nursing Science. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
The International Vaccine Institute, a Seoul, Korea-based international organization, announced today that the Swedish International Cooperation Agency will continue to support IVI's mission to accelerate vaccine research and development for global health with a total contribution of SEK 50 million (approximately 5.24 million USD) over the next five years as part of a longstanding partnership between the Swedish government and IVI.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced the publication of a research article in Bioorganic & Medicinal Chemistry Letters on the anti-tumor activity of RX-8243 and its analogues.
RegeneRx Biopharmaceuticals, Inc. announced today that the Company has been included on MDB Capital Group's "Best & Brightest" innovators list of 150 companies for 2011. Criterion for inclusion is a ranking in the 90th percentile for technology leadership from more than 1,500 companies with U.S. patents granted, as rated by PatentVest®, MDB's proprietary, intellectual property (IP), business intelligence database.
› Verified 9 days ago
Beacon Brook Health Center Location: 89 Wied Drive, Naugatuck, Connecticut 06770 Phone: (203) 729-9889 |